Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy; Phase 1/2 Study of RRMM Patients

Omar Nadeem's research works Dana-Farber Cancer Institute

Cancers, Free Full-Text

Congress and Scientific Presentations at ash

Discussing Modakafusp Alfa as a Potential Treatment in RRMM

Initial results in RRMM with modakafusp alfa: a first-in-class

Interleukin-Based Treatments Find Footing in Ongoing Research

RVd Alone vs Rvd Plus ASCT in Newly Diagnosed Patients

IMF Patient & Family Webinar 2023 - Understanding The New Myeloma

Abstract Book for the 27th Congress of the European Hematology

Shebli ATRASH, Medical Doctor, Hematology Oncology

Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy

Actor and Artist Ice-T Raises Awareness of Myeloma

Results from the first-in-human study of Modakafusp Alfa in Pts

Diagnosis and Therapeutic Advances in Multiple Myeoma

Diagnosis and Therapeutic Advances in Multiple Myeoma